| 1 |
29464018 | Ganglioside GM1 contributes to extracellular/intracellular regulation of insulin resistance, impairment of insulin signaling and down-stream eNOS activation, in human aortic endothelial cells after short- or long-term exposure to TNFα. | 2018 Jan 19 |
1 |
| 2 |
28387617 | Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial. | 2017 May |
1 |
| 3 |
27173510 | Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance. | 2016 Jun 1 |
3 |
| 4 |
26041445 | Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. | 2015 Aug 1 |
2 |
| 5 |
20561942 | The twists and turns of sphingolipid pathway in glucose regulation. | 2011 Jan |
1 |
| 6 |
21570958 | A view on sphingolipids and disease. | 2011 Sep |
1 |
| 7 |
21910085 | Glycosphingolipids and insulin resistance. | 2011 |
5 |
| 8 |
20085539 | Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by sphingolipid depletion. | 2010 Mar 15 |
6 |
| 9 |
19303901 | Glycosphingolipids and insulin resistance. | 2009 May-Jul |
3 |
| 10 |
19587831 | A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes. | 2009 |
2 |
| 11 |
18089699 | Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. | 2008 Mar |
1 |
| 12 |
1459340 | Biphasic effects of exogenous ganglioside GM3 on follicle-stimulating hormone-dependent expression of luteinizing hormone receptor in cultured granulosa cells. | 1992 Oct |
1 |